PSB-CB5

PSB-CB5
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay35279-5 5 mg -

6 - 10 business days*

106.00€
Cay35279-10 10 mg -

6 - 10 business days*

200.00€
Cay35279-25 25 mg -

6 - 10 business days*

419.00€
 
PSB-CB5 is an antagonist of G protein-coupled receptor GPR18 (IC50 = 0.279 µM). It is 36-, 36-,... more
Product information "PSB-CB5"
PSB-CB5 is an antagonist of G protein-coupled receptor GPR18 (IC50 = 0.279 µM). It is 36-, 36-, and 14-fold selective for GPR18 over GPR55, cannabinoid 1 (CB1), and CB2 receptors, respectively. PSB-CB5 (1 µM) inhibits acrosomal exocytosis induced by the endogenous GPR18 ligand arachidonoyl glycine (NAGly, Cay-90051) in human spermatozoa.Formal Name: (2Z)-2-[[3-[(4-chlorophenyl)methoxy]phenyl]methylene]-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-3(2H)-one. CAS Number: 1627710-30-8. Synonyms: CID-85469571. Molecular Formula: C20H17ClN2O2S. Formula Weight: 384.9. Purity: >95%. Formulation: (Request formulation change), A solid. Solubility: DMSO: up to 25mg/mL. lambdamax: 220, 251, 378 nm. SMILES: O=C1N2C(SCCC2)=N/C1=C\C3=CC(OCC4=CC=C(C=C4)Cl)=CC=C3. InChi Code: InChI=1S/C20H17ClN2O2S/c21-16-7-5-14(6-8-16)13-25-17-4-1-3-15(11-17)12-18-19(24)23-9-2-10-26-20(23)22-18/h1,3-8,11-12H,2,9-10,13H2/b18-12-. InChi Key: XJBQRMOGMULGPP-PDGQHHTCSA-N.
Keywords: CID-85469571, (2Z)-2-[[3-[(4-chlorophenyl)methoxy]phenyl]methylene]-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-3(2H)-one
Supplier: Cayman Chemical
Supplier-Nr: 35279

Properties

Application: GPR18 antagonist
MW: 384.9 D
Formula: C20H17ClN2O2S
Purity: >95%
Format: Solid

Database Information

CAS : 1627710-30-8| Matching products
KEGG ID : K08410 | Matching products

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PSB-CB5"
Write a review
or to review a product.
Viewed